Order Article Reprints

Freire Boullosa L, Van Loenhout J, Flieswasser T, Hermans C, Merlin C, Lau HW, Marcq E, Verschuuren M, De Vos WH, Lardon F, et al. Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers. Antioxidants. 2023; 12(3):667. https://doi.org/10.3390/antiox12030667

Freire Boullosa, Laurie, Jinthe Van Loenhout, Tal Flieswasser, Christophe Hermans, Céline Merlin, Ho Wa Lau, Elly Marcq, Marlies Verschuuren, Winnok H. De Vos, Filip Lardon, and et al. 2023. "Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers" Antioxidants 12, no. 3: 667. https://doi.org/10.3390/antiox12030667

Freire Boullosa, L., Van Loenhout, J., Flieswasser, T., Hermans, C., Merlin, C., Lau, H. W., Marcq, E., Verschuuren, M., De Vos, W. H., Lardon, F., Smits, E. L. J., & Deben, C. (2023). Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers. Antioxidants, 12(3), 667. https://doi.org/10.3390/antiox12030667